Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study - Concepedia

Concepedia

Publication | Open Access

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

DOI Full Paper Access

52

Citations

19

References

2023

Year

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan, Peter A. Engel, ABUBAKR A BAJWA, Ashwin Ravichandran, Jeremy Feldman, Amy Hajari Case, Rahul Argula, Victor F. Tapson,

European Respiratory Journal

Abstract

These results support the long-term safety and efficacy of inhaled treprostinil in patients with PH-ILD, and are consistent with the results observed in the INCREASE RCT.

References

	Year	Citations

Page 1